The Liver Graft Before Transplantation

Prof. Dr. Xavier Verhelst, MD, PhD, is a senior hepatologist at the Gastrointestinal and Liver Diseases Department at Ghent University Hospital. Dr. Verhelst is a member of the Global PBC Study Group for primary biliary cholangitis, the International PSC Study Group for primary sclerosing cholangitis (iPSCsg), and the Vascular Liver Disease Group (VALDIG) for vascular liver disease. He has been involved as a primary or subinvestigator in numerous phase I, II, and III clinical studies for new therapies in patients with viral hepatitis, primary liver tumors, primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), autoimmune hepatitis, and liver transplantation. He has given lectures at national and international conferences. He is the author and coauthor of more than 100 peer-reviewed publications. He is a member of the Board of the Flemish Association for Gastroenterology and a member of the Belgian Association for the Study of the Liver, the European Association for the Study of the Liver (EASL), and Belgian Transplant Association.

Section One: Liver transplantation
1. Introduction, history
2. Current practice
3. Outcome
4. Living donation in liver transplantation

Section Two: Assessment of a liver graft
1. Assessment of a donor
2. Assessment of a liver graft
3. Risk related to a suboptimal liver graft
4. Liver procurement; DBD, DCD, living donation
5. The use of machine perfusion in liver transplantation
6. Emerging treatments in graft reconditioning beyond machine perfusion